Why Linguistic Validation Matters in Patient-Facing Materials？

Why Linguistic Validation Matters in Patient-Facing Materials

Language barriers have a significant effect on the cost and quality of healthcare. They usually occur when there is a language gap between patients and medical staff. Bad health outcomes are associated with unfair treatment, such as inadequate care because of linguistic and cultural limitations. It also means people can't get the care they need. According to a recent study carried out in six US hospitals, patients with limited English proficiency experienced adverse events more frequently than those who are fluent in English (Al Shamsi et al., 2020).

Consent forms, usage instructions, patient-reported outcome (PRO) questionnaires, and drug labels are patient-facing materials. Language validation is the way to check that translation is right. It makes sure the meaning and tone are the same for the target community. To ensure patient safety and regulatory preparedness, linguistic validation is not merely a luxury for US healthcare sponsors. Reputable medical translation company Willingjet Life Sciences offers thorough language validation services to assist businesses in converting clinical accuracy into practical understanding.

What is linguistic validation?

Linguistic validation checks for conceptual equivalency. The new words should have the same idea and meaning as the source text. The text must be right and suitable for the cultural and language needs of the people.  It goes much beyond simple translation. Cultural adaptation, readability testing, patient understanding, and documentation of each translation decision are all examples of linguistic validation. Although it frequently occurs, a back-translation step by itself does not guarantee genuine validation. A proper validation process, on the other hand, has several layers of quality control, including back-translation, expert review, forward translation, and clarity testing with actual patients or native speakers (Williams, 2024).

Figure 1. Categories of Validity (Mundhra et al., 2025)

The Impact of Linguistic Validation on Patient Safety

Language barriers have  an impact on the quality of life care. Non-English-speaking communities may receive less information regarding their loved one's illness compared to English-speaking communities (De Moissac & Bowen, 2019).

1. Safeguarding Patient Health

Unclear terms in patient instructions might lead to misuse, negative outcomes, or treatment failure. A basic misinterpretation of dosage, timing, or contraindication might have potentially fatal results. Spanish-speaking patients were more likely than English-speaking patients to exhibit a dosage error, according to a survey of patients upon discharge. In a different study, compared to 2% of patients who received or did not require an interpreter, 27% of patients who believed they required one but did not receive one did not comprehend instructions for taking their prescription (De Moissac & Bowen, 2019).

 2. Preserving the Integrity of Clinical Data

Patient-reported outcome (PRO) data in clinical research must be the same in all study places. Mistakes in translation can alter the patient's perception about questions, ultimately leading to wrong results. Maintaining cognitive equivalence through linguistic validation safeguards data quality and regulatory approval.

3. Guidelines for ethics and informed consent

Review boards (IRBs) and ethics groups advise study participants to know what they are entering into. The purpose of verified translation is to  ensure that non-native English speakers are aware of the study's risks and procedures. This is a fundamental component of moral patient participation. For example, in a retrospective chart review, Schenker et al. (2007) found that people who could not speak English were less likely to have an understanding of informed consent for medical treatments (De Moissac & Bowen, 2019).

4. Regulatory requirements and Quality compliance

Health Canada, the FDA, and the EMA are all regulatory bodies that make sure that information for patients is correct and simple to understand. A written record of language validation is the best way to do it. The FDA may not tell you a set  of ways to translate, but language validation is still a very key component for clinical results evaluations.

How to Do Good Linguistic Validation, Step by Step.

Although particular techniques differ based on the kind of material, a strong validation procedure often consists of the following actions (Ydo et al., 2025).

1. Evaluation of Translatability

Experts examine the original material to look for any possible language or cultural problems before translation starts. To guarantee relevance and clarity in the target language, this helps in the adaptation of idioms, metaphors, or culturally charged terms.

2. Translation Forward

Two or more skilled native translators translate the source text into the target language. It is best if they have clinical or medical experience.

3. Compatibility

Then, a third translator or project manager compares the forward translations. That person makes a single, clear version. This final copy best shows the original meaning.

4. Back-Translation and Review

Finally, the reconciled translation is translated back into the original language by another linguist. It becomes simpler to identify any conceptual mistakes or misunderstandings that may have come into the translated text as a result.

5. Evaluation by Sponsors and Experts

Sponsors and medical professionals check the translation for clinical and scientific accuracy. This phase guarantees that medical concepts and terminology are in line with accepted usage in the therapeutic field.

6. Cognitive Evaluation

We interview native speakers of the target population, which is typically actual patients or laypeople, to assess their understanding of the translated content. This guarantees the original's readability, cultural relevance, and emotional tone.

7. Proofreading and Finalization

The final draft is reviewed by linguists for consistency, grammar, and formatting. A validation report describing the approach, choices taken, and participant feedback.

Figure 2. Linguistic validation Framework (Williams, 2024)

Outcomes of Skipped Validation

Ignoring language validation can result in serious legal and practical problems

●       Regulatory delays can cause delays in clinical study approval or product releases, as reviewers may reject materials or require revalidation.

●       Inaccurate data from poorly translated PROs invalidates entire datasets and compromises study results.

●       Inaccurate interpretation of drug or device instructions may lead to recalls, adverse effects for patients, or legal action.

●       Materials that are unclear or confusing harm the sponsor's and the healthcare provider's credibility.

In other words, failing to execute validation correctly from the beginning can cost more in terms of time, money, and trust than doing it correctly (Kelvin Quan, JD MPH, 2011 ; Horváth, 2023).

How Linguistic Validation Is a Strength of Willingjet Life Sciences

With extensive knowledge of pharmaceuticals, biotechnology, and medical equipment, Willingjet Life Sciences is an expert in medical translation and linguistic validation. It is unique in that it combines scientific accuracy with patient-centered understanding.

1. Domain-Specific Expertise

Willingjet uses linguists with scientific and medical training to ensure that translations convey the meaning of intricate clinical concepts as well as the words.

2.  Standardized Quality System

Quality requirements of ISO 9001 and ISO 17100 are being met by our tests. This guarantees integrity and legal compliance in all projects.

3. Thorough Validation Procedures

Willingjet provides end-to-end services in accordance with ISPOR and EMA criteria, including cognitive debriefing, report writing, and translatability assessment.

4. A patient-focused approach

We care about patients and their way of life. Our teams test the translated materials for  patients. And makes sure that it is easy to understand and fits their culture and linguistic background.

5. Affordable Options for Multinational Trials

Willingjet is perfect for translating patient booklets for Spanish-speaking patients in the US or for multi-country clinical trials since it provides comprehensive validation across more than 100 languages. To ensure that sponsors may confidently submit certified papers to regulatory bodies or ethical committees, the organization ensures authenticity and compliance in every project.

Key Recommendations for US Sponsors and Research Teams

1. Make a plan in advance and incorporate linguistic validation into the budget and study design.

2. Depending on the type of information being used, adjust the extent of validation; for instance, a patient record requires more testing than a quick label insert.

3. Translators must understand medical language and the literacy level of the target community.

4 Keep records of approvals. Save notes from patient testing. Track the translation steps. When conducting inspections, regulators frequently request these.

5. Use simple vocabulary and assess understanding. When patients are unable to understand medical translations, even correct ones fail.

6. Working with a committed partner such as Willingjet guarantees that language validation is both audit-ready and supported by science.

Concluding remarks

By bridging the gap between language and understanding, linguistic validation ensures that every patient, regardless of background, receives the same level of safety, respect, and clarification in communication. Linguistic validation is a managerial responsibility for US-based businesses and manufacturers with global operations. It is a planned investment in brand integrity, patient safety, and quality. Willingjet helps in converting difficult clinical data into validated patient communication through its committed medical translation teams,  validation procedures, and an understanding of global laws and regulations. This enables healthcare organizations to meet legal standards and improve patient outcomes

References

Al Shamsi, H., Almutairi, A. G., Al Mashrafi, S., & Al Kalbani, T. (2020). Implications of language barriers for healthcare: A systematic review. Oman Medical Journal, 35(2), e122–e122. https://doi.org/10.5001/omj.2020.40

De Moissac, D., & Bowen, S. (2019). Impact of language barriers on quality of care and patient safety for official language minority francophones in canada. Journal of Patient Experience, 6(1), 24–32. https://doi.org/10.1177/2374373518769008

Horváth, Á. (2023). Patient safety communication in translation: A corpus-based genre analysis of the Hungarian-English translation of informed consent forms [Eötvös Loránd Tudományegyetem]. https://doi.org/10.15476/ELTE.2022.208

Kelvin Quan, JD MPH,. (2011). The high costs of language barriers in medical malpractice. National Law Health Program.

Mundhra, S. K., Sharma, R., & Kochhar, R. (2025). Bridging the language and cultural gap: Translating and validating patient-reported outcomes in regional languages. Indian Journal of Gastroenterology, 44(5), 591–594. https://doi.org/10.1007/s12664-025-01848-7

Williams, H. (2024). Harmonising linguistic validation with AI: Precision, efficiency, and the human touch in patient-reported outcome translation. Medical Writing, 33(1), 66–69. https://doi.org/10.56012/lxmw9690

Ydo, C. B., Poulsen, L., Breitkopf, T., Klassen, A. F., & Sørensen, J. A. (2025). Danish translation, linguistic validation, and cultural adaption of SCAR-Q. European Journal of Plastic Surgery, 48(1), 73. https://doi.org/10.1007/s00238-025-02334-1